Juvenescence is a biopharmaceutical firm that focuses on developing therapeutics for ageing. Juvenescence was founded in 2017. Juvenescence's headquarters is located in Liverpool, England, GB L19 8EE. It has raised 165.4M in 4 rounds. The latest round...
Juvenescence's Co-Founder & CEO, Greg Bailey, currently has an approval
rating of 70%. Juvenescence's primary competitors are
There are no competitors identified for Juvenescence
There have been no acquisitions found related to Juvenescence